Trevor Dighton, the outgoing Chief Financial Officer (CFO) of security group G4S, on Wednesday reduced his stake by 400,000 shares ahead of his departure at the end of April. Dighton, who announced his plans to retire from the company last month, traded in the shares at 295.80p each, resulting in
Read moreThe FTSE Small Caps index was up 0.4 percent in mid-morning trade, mirroring similar gains by the FTSE 100 index which is ahead by 0.5 percent, while the FTSE 250 index adds 0.7 percent. Goodwin gains 4.2 percent as the mechanical and refractory engineer reports a rise in first-half pre-tax profits
Read moreEngineering firm Goodwin revealed a considerable climb in revenue in its half-yearly results Wednesday following an increase in turnover and growth in the market. The group reported revenue of £68m for the six months ended October 31st, up 26% from £54.3m in the comparative period the year before.
Read moreClinical-stage stem cell group ReNeuron has achieved further significant milestones with its ReN001 and ReN009 programmes in stroke and critical limb ischaemia, with the filing of two further clinical trial applications to progress the clinical development of these novel therapies. Michael Hunt, Chi
Read moreRichard Goodwin, the Managing Director of Goodwin, sold just over 5,000 shares in the company on Friday, the same day the engineering and steel castings firm reported strong growth in profits. The director traded in the shares at 1,330p a pop, earnings himself £67,404 and reducing his stake to 31,3
Read moreEngineering and steel castings firm Goodwin has reported strong growth in profits but has restricted its dividend to allow for greater investment. In the 12 months to the end of April, pre-tax profits at the Stoke headquartered firm were £12.3m an increase of 51% on 2010/11. Revenues for the full
Read moreJean Stéphenne, president and general manager of Biologicals at GlaxoSmithKline, has sold off 20,000 shares just days after the firm off-loaded its Consumer Healthcare Consumer Healthcare over-the-counter brands. The director, who sold the shares at £14.408, has overseen Biologicals since 1991. E
Read moreMechanical engineering firm Goodwin lost almost a tenth of its value on Friday morning after full-year results revealed a 38% slump in profits. Pre-tax profit fell from £13.3m to £8.2m, while profit after taxation more than halved to £4.2m. Part of the £5.1m drop in pre tax profit relates to incr
Read moreUranium company Forte Energy has been testing for rare earth elements (REE) in Guinea and the latest assay results indicate "provide a higher level of encouragement that a substantial body of REE mineralisation may exist within the company's 100% owned Firawa uranium project." "REE assays from thes
Read moreAn ORA Capital Partners non-exec has invested more than £15,000 in the company. James Ede-Golightly bought 19,176 shares for his SIPP at 80p each. This takes his stake in AIM-quoted ORA to 199,176 shares. Cambridge graduate Ede-Golightly is a former analyst with Merrill Lynch and Commerzbank.
Read moreOn Monday, BP non-executive director George David acquired 18,815 ADSs in the oil and gas giant for $56.89 each, followed by a further 1,185 ADSs at the same price the following day. This equates to 120,000 ordinary shares in total. The equivalent share price is 568.9p. This takes David's stake in
Read moreLegal & General's new chief financial officer Dr Nigel Wilson has bought £670,000 worth of shares less than seven weeks after joining the board of the insurer. Dr Wilson tookup his appointment on 1 September 2009. He did not own any shares at the time. Dr Wilson bought 760,948 shares at 88p each o
Read moreNigel Wilson, a senior independent director at the car parts and bicycle retailer Halfords, has nearly doubled his stake in the firm, spending just less than £70,000 on shares. He took 20,000 at 349p a time and now has 41,000. Wilson, who is also chief financial officer at the business publisher U
Read more